Overcoming Challenges in Coronavirus Disease 19 Translational Research

Jonathan Z Li; Xu G Yu

doi:10.1093/infdis/jiaa397

Overcoming Challenges in Coronavirus Disease 19 Translational Research

J Infect Dis. 2020 Sep 14;222(8):1254-1255. doi: 10.1093/infdis/jiaa397.

Authors

Jonathan Z Li¹, Xu G Yu²

Affiliations

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Cambridge, Massachusetts, USA.

Abstract

This perspective details the challenges faced in starting a coronavirus disease 2019 (COVID-19) biobank as part of a collaborative effort to accelerate translational research. Barriers to COVID-19 translational research are surmountable and necessary in the effort to combat this pandemic.

Keywords: COVID-19; biobank; biorepository; translational research.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / diagnosis*
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy*
Coronavirus Infections / virology
Humans
Medical Laboratory Personnel
Pandemics
Personal Protective Equipment / supply & distribution
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy*
Pneumonia, Viral / virology
Research Design
SARS-CoV-2
Specimen Handling / methods
Specimen Handling / standards
Translational Research, Biomedical